HD2A RASC-SUD Implementation Support Core
HD2A RASC-SUD 实施支持核心
基本信息
- 批准号:10596437
- 负责人:
- 金额:$ 59.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:Action ResearchAdoptionAdvocacyAfrican American populationAmericanAsian AmericansBehavior TherapyBlack raceCOVID-19 pandemicCaringCatalogsClinical Trials NetworkCommunitiesContinuity of Patient CareDataDeath RateDissemination and ImplementationEngineeringEvaluationFacultyFundingGoalsHarm ReductionHealthcareHealthcare SystemsHelping to End Addiction Long-termInterventionInvestmentsJusticeLeadLeadershipLearningLinkMeasuresMediationMethodologyMethodsMotivationNational Institute of Drug AbuseNative AmericansNative HawaiianNeedlesNot Hispanic or LatinoOpioidOverdoseOverdose reductionPacific IslanderPainPharmaceutical PreparationsPharmacologyPhasePoliciesPreventionPublic HealthPublic Health PracticePublicationsRecovery SupportResearchResearch InstituteResearch PersonnelResourcesRoleScienceScientistServicesSubstance Use DisorderSystemTechnology TransferTimeTranslatingTranslational ResearchUninsuredUnited States National Institutes of HealthUnited States Substance Abuse and Mental Health Services Administrationaddictionbasecaucasian Americandissemination scienceevidence basegaps in accesshealth equityimplementation facilitationimplementation interventionimplementation measuresimplementation outcomesimplementation researchimplementation scienceimplementation strategyimprovedinnovationknowledge basemarginalized populationopioid use disorderoverdose deathoverdose preventionoverdose riskprogram disseminationpsychosocialresource guidesshared decision makingsocial stigmasubstance use treatmentsymposium
项目摘要
This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to improve treatment for opioid misuse and addiction and to develop concrete strategies capable of providing rapid and durable solutions to the opioid crisis. SUD IMPLEMENTATION SUPPORT CORE: PROJECT SUMMARY/ABSTRACT Drug overdose fatalities have continued to rise despite massive federal investment in developing and disseminating evidence-based pharmacological and behavioral interventions for substance use disorders (SUDs). Attempts to move the needle on overdose deaths have stalled because of challenges translating research knowledge and evidence-based SUD interventions into public health practice. Access to evidence- based SUD interventions remains woefully limited throughout the U.S. health care system, particularly for historically marginalized populations such as Black/African-Americans, Native Hawaiians/Pacific Islanders, Asian Americans, and the uninsured. Equitable translation of research findings into practice is the domain of dissemination and implementation (D&I) science. A core component of the HD2A Research Adoption Support Center (RASC), the SUD Implementation Support (SUD-IS) Core will bring the best of D&I science to the Innovation Projects to guide the selection, implementation, and sustainment of evidence-based, locally appropriate SUD interventions to reduce overdose risk in hard hit communities. Core leadership will unify implementation scientists and SUD researchers - with the proximal goal of enhancing the impact of the Innovation Projects and the ultimate goal of improving public health - by leveraging cutting-edge D&I measures and methods, and capitalizing on our team’s commitment to team science. Thematically and operationally in tandem with the RASC and other cores, the SUD-IS Core will elevate the Innovation Projects through dynamic and iterative phases of ASSESS, ASSIST, and ADVANCE. We will first ASSESS the current state of evidence for SUD interventions in order to: a) develop a systematic catalog of evidence-based and emerging practices; and b) develop an SUD Intervention D&I Resource Guide for the Innovation Projects and any SUD intervention implementation project based on five key D&I constructs (e.g., contextual determinants, evidentiary support for the intervention, stakeholder engagement, implementation strategies, and implementation outcomes including equity and stigma). We will then ASSIST the Innovation Projects using information gathered in the ASSESS phase in order to: a) enhance motivation to enhance their studies with tailored D&I approaches that draw upon Core expertise; b) provide a D&I Implementation Support Plan and use a shared decision-making approach to determine how best to offer technical assistance; and c) co-lead the RASC Learning Collaborative. Finally, we will ADVANCE the Innovation Projects’ activities with respect to sustainment, equity, and stigma reduction: linking projects with the field at large, promoting impacts on policy/financing and facilitating ongoing stakeholder engagement towards advocacy. Perfectly aligned with the RASC, together we take a major step toward closing the persistent and inequitable gap of access to proven pharmacologic and psychosocial treatments for SUD.
这项研究是 NIH 帮助消除成瘾长期 (HEAL) 计划的一部分,该计划旨在加快科学解决国家阿片类药物公共卫生危机的速度。 NIH HEAL Initiative 支持 NIH 的研究,以改善阿片类药物滥用和成瘾的治疗,并制定能够为阿片类药物危机提供快速、持久解决方案的具体策略。 SUD 实施支持核心:项目摘要/摘要 尽管联邦投入巨资开发和传播针对药物滥用障碍 (SUD) 的循证药理学和行为干预措施,但药物过量死亡人数仍在持续上升。由于将研究知识和基于证据的 SUD 干预措施转化为公共卫生实践方面存在挑战,解决药物过量死亡问题的尝试已陷入停滞。令人遗憾的是,在整个美国医疗保健系统中,获得基于证据的 SUD 干预措施仍然受到严重限制,特别是对于历史上被边缘化的人群,如黑人/非裔美国人、夏威夷原住民/太平洋岛民、亚裔美国人和没有保险的人。将研究成果公平地转化为实践是传播和实施 (D&I) 科学的领域。作为 HD2A 研究采用支持中心 (RASC) 的核心组成部分,SUD 实施支持 (SUD-IS) 核心将为创新项目带来最好的 D&I 科学,以指导选择、实施和维持基于证据的、适合当地的 SUD 干预措施,以减少重灾区的用药过量风险。核心领导层将通过利用尖端的 D&I 措施和方法,并利用我们团队对团队科学的承诺,团结实施科学家和 SUD 研究人员,其近期目标是增强创新项目的影响,最终目标是改善公众健康。在主题和操作上,SUD-IS 核心将与 RASC 和其他核心相结合,通过动态和迭代的 ASSESS、ASSIST 和 ADVANCE 阶段来提升创新项目。我们将首先评估 SUD 干预措施的证据现状,以便: a) 制定基于证据和新兴实践的系统目录; b) 根据五个关键的 D&I 结构(例如背景决定因素、干预的证据支持、利益相关者参与、实施策略以及包括公平和耻辱在内的实施结果),为创新项目和任何 SUD 干预实施项目制定 SUD 干预 D&I 资源指南。然后,我们将使用在评估阶段收集的信息协助创新项目,以便: a) 通过利用核心专业知识的定制 D&I 方法来增强加强研究的动力; b) 提供 D&I 实施支持计划并使用共同决策方法来确定如何最好地提供技术援助; c) 共同领导 RASC 学习协作组织。最后,我们将推进创新项目在维持、公平和减少耻辱方面的活动:将项目与整个领域联系起来,促进对政策/融资的影响,并促进利益相关者持续参与宣传。我们与 RASC 完全一致,共同朝着缩小 SUD 获得经过验证的药物和心理社会治疗方面持续且不公平的差距迈出了重要一步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sara J. Becker其他文献
Evaluation of sex disparities in opioid use among ED patients with sickle cell disease, 2006-2015.
2006-2015 年镰状细胞病 ED 患者阿片类药物使用性别差异的评估。
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:3.6
- 作者:
T. Wilson;Shih;Sara J. Becker;J. Schuur;F. Beaudoin - 通讯作者:
F. Beaudoin
Randomized Clinical Trials in Behavioral Medicine
行为医学随机临床试验
- DOI:
10.1007/978-0-387-93826-4_5 - 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
K. Freedland;Sara J. Becker;J. Blumenthal - 通讯作者:
J. Blumenthal
Interventions for Substance Use Disorders in Adolescents: A Systematic Review
青少年药物使用障碍的干预措施:系统评价
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
D. Steele;Sara J. Becker;Kristin J. Danko;E. Balk;I. Saldanha;G. Adam;S. Bagley;C. Friedman;A. Spirito;Kelli Scott;E. Ntzani;Imani Saeed;Bryant T. Smith;J. Popp;T. Trikalinos - 通讯作者:
T. Trikalinos
Proceedings of the 13th annual conference of INEBRIA
- DOI:
10.1186/s13722-016-0062-9 - 发表时间:
2016-09-01 - 期刊:
- 影响因子:3.200
- 作者:
Rod Watson;James Morris;John Isitt;Pablo Barrio;Lluisa Ortega;Antoni Gual;Kenneth Conner;Tracy Stecker;Stephen Maisto;Sophie Paroz;Caroline Graap;Véronique S Grazioli;Jean-Bernard Daeppen;Susan E Collins;Nicolas Bertholet;Jennifer McNeely;Vlad Kushnir;John A. Cunningham;Iain K Crombie;Kathryn B Cunningham;Linda Irvine;Brian Williams;Falko F Sniehotta;John Norrie;Ambrose Melson;Claire Jones;Andrew Briggs;Peter Rice;Marcus Achison;Andrew McKenzie;Elena Dimova;Peter W Slane;Véronique S. Grazioli;Susan E. Collins;Sophie Paroz;Caroline Graap;Jean-Bernard Daeppen;Stéphanie Baggio;Marc Dupuis;Joseph Studer;Gerhard Gmel;Molly Magill;Véronique S. Grazioli;Robert J. Tait;Lucinda Teoh;Erin Kelty;Elizabeth Geelhoed;David Mountain;Gary K. Hulse;Elina Renko;Shannon G. Mitchell;David Lounsbury;Zhi Li;Robert P. Schwartz;Jan Gryczynski;Arethusa S. Kirk;Marla Oros;Colleen Hosler;Kristi Dusek;Barry S. Brown;Deborah S. Finnell;Aisha Holloway;Li-Tzy Wu;Geetha Subramaniam;Gaurav Sharma;Sara Wallhed Finn;Sven Andreasson;Robert D. Dvorak;Matthew P. Kramer;Brittany L. Stevenson;Emily M. Sargent;Tess M. Kilwein;Sion K. Harris;Lon Sherritt;Sarah Copelas;John R. Knight;Noreen D Mdege;Jim McCambridge;Gallus Bischof;Anja Bischof;Jennis Freyer-Adam;Hans-Juergen Rumpf;Niamh Fitzgerald;Lisa Schölin;Paul Toner;Jan R. Böhnke;Laura J. Veach;Olivia Currin;Leigh Z. Dongre;Preston R. Miller;Elizabeth White;Emily C. Williams;Gwen T. Lapham;Jennifer J. Bobb;Anna D. Rubinsky;Sheryl L. Catz;Susan Shortreed;Kara M. Bensley;Katharine A. Bradley;Joanna Milward;Paolo Deluca;Zarnie Khadjesari;Rod Watson;Stephanie Fincham-Campbell;Colin Drummond;Kathryn Angus;Linda Bauld;Sophie Baumann;Katja Haberecht;Inga Schnuerer;Christian Meyer;Hans-Jürgen Rumpf;Ulrich John;Beate Gaertner;Marion Barrault-Couchouron;Marion Béracochéa;Vincent Allafort;Valérie Barthélémy;Hervé Bonnefoi;Emmanuel Bussières;Véronique Garguil;Marc Auriacombe;Marianne Saint-Jacques;Michel Dorval;Katia M’Bailara;Lidia Segura-Garcia;Nuria Ibañez-Martinez;Juan Manuel Mendive-Arbeloa;Manel Anoro-Perminger;Pako Diaz-Gallego;Mª Angeles Piñar-Mateos;Joan Colom-Farran;Marianthi Deligianni;Bertrand Yersin;Angeline Adam;Constance Weisner;Felicia Chi;Wendy Lu;Stacy Sterling;Kevin L. Kraemer;Kathleen A. McGinnis;David A. Fiellin;Melissa Skanderson;Adam J. Gordon;Jonathan Robbins;Susan Zickmund;P. Todd Korthuis;E. Jennifer Edelman;Nathan B. Hansen;Christopher J. Cutter;James Dziura;Lynn E. Fiellin;Patrick G. O’Connor;Stephen A. Maisto;Roger Bedimo;Cynthia Gilbert;Vincent C. Marconi;David Rimland;Maria Rodriguez-Barradas;Michael Simberkoff;Amy C. Justice;Kendall J. Bryant;Anne H Berman;Gillian W Shorter;Jeremy W Bray;Carolina Barbosa;Magnus Johansson;Reid Hester;William Campbell;Maria Lucia O. Souza Formigoni;André Luzi Monezi Andrade;Laisa Marcorela Andreoli Sartes;Christopher Sundström;Niels Eék;Martin Kraepelien;Viktor Kaldo;Claudia Fahlke;Lynn Hernandez;Sara J. Becker;Richard N. Jones;Hannah R. Graves;Anthony Spirito;Silke Diestelkamp;Lutz Wartberg;Nicolas Arnaud;Rainer Thomasius;Jacques Gaume;Véronique Grazioli;Cristiana Fortini;Zelra Malan;Bob Mash;Katherine Everett-Murphy;Véronique S. Grazioli;Joseph Studer;M. Mohler-Kuo;Nicolas Bertholet;Gerhard Gmel;Lawrence Doi;Helen Cheyne;Ruth Jepson;Vanesa Luna;Leticia Echeverria;Silvia Morales;Teresa Barroso;Ângela Abreu;Cosma Aguiar;Duncan Stewart;Angela Abreu;Riany M. Brites;Rafael Jomar;Gerson Marinho;Pedro Parreira;J. Paul Seale;J. Aaron Johnson;Dena Henry;Sharon Chalmers;Freida Payne;Linda Tuck;Akula Morris;Cátia Gonçalves;Bettina Besser;Cristina Casajuana;Hugo López-Pelayo;María Mercedes Balcells;Lídia Teixidó;Laia Miquel;Joan Colom;Kimberly A. Hepner;Katherine. J. Hoggatt;Andy Bogart;Susan. M. Paddock;Sarah L Hardoon;Irene Petersen;Fiona L Hamilton;Irwin Nazareth;Ian R. White;Louise Marston;Paul Wallace;Christine Godfrey;Elizabeth Murray;Hana Sovinová;Ladislav Csémy - 通讯作者:
Ladislav Csémy
“Sounds like CSI:” How consumers of adolescent substance use disorder treatment perceive the term “evidence-based practice”
“听起来像犯罪现场调查:”青少年物质使用障碍的消费者如何看待“循证实践”一词的治疗
- DOI:
- 发表时间:
2015 - 期刊:
- 影响因子:3.7
- 作者:
Sara J. Becker;Miriam M Midoun;A. Spirito - 通讯作者:
A. Spirito
Sara J. Becker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sara J. Becker', 18)}}的其他基金
HD2A RASC-SUD Implementation Support Core
HD2A RASC-SUD 实施支持核心
- 批准号:
10708983 - 财政年份:2022
- 资助金额:
$ 59.12万 - 项目类别:
C-DIAS RP 2: Implementing contingency management for stimulant use in specialty addiction treatment organizations
C-DIAS RP 2:在专业成瘾治疗组织中实施兴奋剂使用应急管理
- 批准号:
10668488 - 财政年份:2022
- 资助金额:
$ 59.12万 - 项目类别:
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
在新英格兰各地的阿片类药物治疗中心实施应急管理:一项混合 3 型试验
- 批准号:
10665470 - 财政年份:2022
- 资助金额:
$ 59.12万 - 项目类别:
C-DIAS RP 2: Implementing contingency management for stimulant use in specialty addiction treatment organizations
C-DIAS RP 2:在专业成瘾治疗组织中实施兴奋剂使用应急管理
- 批准号:
10493960 - 财政年份:2022
- 资助金额:
$ 59.12万 - 项目类别:
Improving Outcomes of Adolescents in Residential Substance use Treatment via a Technology-Assisted Parenting Intervention
通过技术辅助育儿干预改善青少年住宅药物滥用治疗的结果
- 批准号:
10666175 - 财政年份:2021
- 资助金额:
$ 59.12万 - 项目类别:
Neighborhood perceptions and response to a technology-assisted parenting intervention for youth substance use
社区对针对青少年药物滥用的技术辅助育儿干预的看法和反应
- 批准号:
10836689 - 财政年份:2021
- 资助金额:
$ 59.12万 - 项目类别:
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
在新英格兰各地的阿片类药物治疗中心实施应急管理:一项混合 3 型试验
- 批准号:
10400426 - 财政年份:2018
- 资助金额:
$ 59.12万 - 项目类别:
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
在新英格兰各地的阿片类药物治疗中心实施应急管理:一项混合 3 型试验
- 批准号:
10215461 - 财政年份:2018
- 资助金额:
$ 59.12万 - 项目类别:
Adolescents with Substance Use Disorders Transitioning from Residential Treatment to the Community: Improving Outcomes via a Computer Assisted Parenting Program
患有药物滥用障碍的青少年从住院治疗过渡到社区:通过计算机辅助育儿计划改善治疗结果
- 批准号:
9034960 - 财政年份:2016
- 资助金额:
$ 59.12万 - 项目类别:
Adolescents with Substance Use Disorders Transitioning from Residential Treatment to the Community: Improving Outcomes via a Computer Assisted Parenting Program
患有药物滥用障碍的青少年从住院治疗过渡到社区:通过计算机辅助育儿计划改善治疗结果
- 批准号:
9263967 - 财政年份:2016
- 资助金额:
$ 59.12万 - 项目类别:
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 59.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 59.12万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 59.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 59.12万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 59.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 59.12万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 59.12万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 59.12万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 59.12万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 59.12万 - 项目类别:
Standard Grant